| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Revenue | $820.6M | +14.5% |
| Cost of Revenue | $502.0M | +16.0% |
| Gross Profit | $318.6M | +12.2% |
| R&D Expense | $100.7M | +3.1% |
| SG&A Expense | $158.8M | +38.7% |
| Operating Income | $40.8M | -43.2% |
| Pre-tax Income | $44.5M | -27.7% |
| Income Tax | $882K | -53.4% |
| Net Income | $43.6M |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $40.9M | -44.3% |
| Accounts Receivable | $102.0M | +45.0% |
| Inventory | $144.1M | -4.0% |
| Current Assets | $606.5M | +17.6% |
| Total Assets | $1.12B | +10.3% |
| Current Liabilities | $172.2M | +18.8% |
| Long-term Debt | $30.0M | +7.1% |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.3M | -108.6% |
| Capital Expenditures | $22.8M | -0.7% |
| Investing Cash Flow | -$28.5M | +44.9% |
| Financing Cash Flow | -$2.9M | +87.5% |
| Free Cash Flow | -$24.1M | -213.8% |
| -26.9% |
| EPS (Basic) | $1.56 | -28.8% |
| EPS (Diluted) | $1.55 | -28.9% |
| Stockholders' Equity |
| $886.5M |
| +7.7% |